Ceryvyn Therapeutics Ltd
OPT
Rang în acțiuni
#31794
Opthea Limited is an Australian clinical-stage biopharmaceutical company... Opthea Limited is an Australian clinical-stage biopharmaceutical company focused on developing and commercializing therapies primarily for eye diseases. The foundation of its development efforts lies in its intellectual property portfolio, which targets Vascular Endothelial Growth Factors (VEGF-C, VEGF-D, and VEGF Receptor-3). This technology is designed to address conditions linked to the growth of blood and lymphatic vessels, as well as vascular leakage. The company's leading asset, OPT 302, is a soluble form of VEGFR3 currently undergoing clinical trials. This novel therapy aims to treat wet neovascular age-related macular degeneration (wet AMD) and diabetic macular edema (DME). OPT 302 is distinguished as a first-in-class VEGF-C/D inhibitor, intended to be used in conjunction with VEGF-A inhibitors for the treatment of wet AMD and various other retinal diseases. Originally incorporated in 1984 as Circadian Technologies Limited, the company rebranded to Opthea Limited in December 2015 and is headquartered in South Yarra, Australia.
Preț acțiune
$0.00846342
Ultima sincronizare: 2026-07-27
Capitalizare de piață
$11.27M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
-99.75%
Țară
AU
Tranzacționează Ceryvyn Therapeutics Ltd (OPT)
Categorie
Healthcare
Istoric al prețului acțiunii pentru Ceryvyn Therapeutics Ltd (OPT)
Cel mai mare preț de închidere: $3.41 pe 2025-04-01
Cel mai mic preț de închidere: $13.17 pe 2020-10-01
Cel mai mic preț de închidere: $13.17 pe 2020-10-01
Istoric al prețului acțiunii pentru Ceryvyn Therapeutics Ltd din 2020 până în 2026
Evoluția anuală a prețului acțiunii
| An | Performanță |
|---|---|
| 2025 | -4.06% |
| 2024 | 37.44% |
| 2023 | -49.05% |
| 2022 | -27.97% |
| 2021 | -41.46% |
| 2020 | 0.00% |
Prețul acțiunii pentru companii similare sau concurente
| Companie | Preț acțiune | Variație 1an% | Țara |
|---|---|---|---|
| $518.71 | 21.68% |
US
|
|
| $247.50 | 800.33% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $886.30 | 6.17% |
NL
|
|
| $752.87 | 7.40% |
CH
|
